EVAX Inc. is the manufacturing and commercialization subsidiary of Enepret Incorporated, a company founded in 2017 to commercialize triterpene-production technologies developed at the University of Kentucky. Its lean team brings together synthetic-biology researchers and pharmaceutical manufacturing specialists to help vaccine developers move from early research into clinical work with non-animal adjuvants and their key ingredients. EVAX manufactures these materials in a 3,500-square-foot facility at the West Virginia University Innovation Corporation in Morgantown.
NovavaxHeadquartered in Gaithersburg, Maryland, Novavax is a biotech company that develops vaccines and vaccine technologies, pairing protein-based nanoparticles with its proprietary Matrix-M® adjuvant. Its platform underpins marketed vaccines for COVID-19 and malaria, while the company continues in-house R&D and works with pharmaceutical, research and government partners to advance additional medicines. Novavax also conducts R&D and Matrix-M manufacturing in Uppsala, Sweden.GAITHERSBURG, MD
IDT BiologikaFounded in 1921, IDT Biologika is a Dessau-Rosslau-based global CDMO that develops and manufactures vaccines, viral vectors, biologics and sterile injectables from early development through commercial supply. Its particular strength is more than a century of experience working with live viruses, supported by BSL-2 facilities, integrated process development and manufacturing, and in-house quality and analytical services. Now part of SK bioscience, the company employs about 1,600 people and serves pharmaceutical and biotechnology customers as well as governments worldwide.ROCKVILLE, MD
Benevira, IncBenevira is a privately owned synthetic biology company developing and manufacturing antiviral biologics, therapeutics, and consumer health products. Its technology targets viral evolutionary bottlenecks to create sustainable treatments and prophylactics for emerging and established viral diseases, including COVID-19 and influenza.NEW YORK, NY